Jefferies Starts Novavax (NVAX) at Buy, $200 PT; Set to Become Major COVID-19 Vaccine Player
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 12.56 +2.10 (20.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.46 | 52 Week High | $9.23 | |||
| Open | $10.47 | 52 Week Low | $1.16 | |||
| Day High | $13.39 | P/E | N/A | |||
| Day Low | $10.28 | EPS | $-0.30 | |||
| Volume | 28,673,354 | |||||
